U.S. Leadership On HIV/AIDS, TB, Malaria At ‘Tipping Point’

The Hill: American leadership against deadly epidemics reaches a decision point
Chris Collins, president of Friends of the Global Fight

“What is the end goal of America’s considerable investment in tackling the deadliest infectious diseases of our time? Americans should be proud that U.S. leadership against AIDS, tuberculosis (TB), and malaria has saved tens of millions of lives and helped dramatically to reduce their devastation. But what should be the long-term objective of these investments? Whether you are looking from the perspective of lives saved, U.S. health security, global stability, economic growth, or American trade interests, the answer is clear: We need to focus on ending these three epidemics for good. The epidemics of AIDS, TB, and malaria are each at a tipping point. … All this means that American policy is at a tipping point, too. Today the world is underinvesting in efforts to end the biggest epidemics; an expanded effort is needed to get on track. … Ending these epidemics can be a legacy for the United States. Now is the time to rededicate ourselves to global health leadership, and challenge the rest of the world to join us in a push to the finish line” (4/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.